Chemiluminescent Immunoassay (CLIA)
To follow patients with neoplasm and to evaluate the effect of antineoplastic therapy, particularly in pancreatic and colorectal carcioma. Clinical relevance has also been shown in the follow-up management of patients with breast, lung, prostatic and ovarian carcinoma.
Adult nonsmoker up to 3.0 ng/mL, Adult smoker up to 5.0 ng/mL.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
CEA levels are elevated in smokers, former smokers, patients with inflammatory bowel disease, and patients with noncolorectal or pancreatic neoplasms
- Glucuronidase, Beta
- CARCINOEMBRYONIC ANTIGEN
- BETA-GLUCORONIDASE, CSF
STAT requests for this test will be performed on a STAT basis (supervisory staff approval is not required).
Collect specimen in an SST or red top tube. Refrigerate and send intact specimen within 8 hours of collection. Alternatively, centrifuge, aliquot serum into a plastic vial and refrigerate up to 48 hours or freeze for longer storage.